Collectively these data provide detailed mechanistic evidence for a role for LPA-LPAR3 dependent signaling in a unique subset of cancer stem cells located at the tumor-NTL margin in HCC patients. This evidence concerns the gene LPAR3 and hepatocellular carcinoma.